SCHEMBL19764152

SCHEMBL19764152

Fc1ccccc1N/N=C/c1ccc(-c2cccc(/C=N/Nc3ccccc3F)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 12/20 0.47
NPC1 O15118 11/20 0.47
SMN1; SMN2 Q16637 8/20 0.47
MEN1 O00255 8/20 0.47
KMT2A Q03164 8/20 0.47
MAPT P10636 6/20 0.47
ALDH1A1 P00352 5/20 0.47
KCNH2 Q12809 4/20 0.46
GAA P10253 7/20 0.45
KDM4E B2RXH2 3/20 0.45
NFKB1 P19838 2/20 0.45
NFKB2 Q00653 2/20 0.45
RELA Q04206 2/20 0.45
LMNA P02545 3/20 0.43
HPGD P15428 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.40
NOX1 Q9Y5S8 1/20 0.40
POLB P06746 1/20 0.40
GFER P55789 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21626683 0.89 KCNH2 (0.50) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL20625512 0.86 KCNH2 (0.62) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL21626682 0.86 KCNH2 (0.50) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL5429720 0.83 RAB9A (0.57) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL19764151 0.80 KCNH2 (0.56) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL21626666 0.80 MAPT (0.59) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL19764161 0.79 NOX1 (0.68) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL20625511 0.78 KCNH2 (0.58) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL20625517 0.78 RAB9A (0.49) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL21626837 0.78 NPC1 (0.73) RAB9ANPC1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200024224-A1 ANTIFUNGAL COMPOUNDS AND METHODS OF FORMING THE SAME UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2020-01-23 US disclosed
US-10173968-B2 Bishydrazone-based antifungal agents UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2019-01-08 US disclosed
US-20180009741-A1 BISHYDRAZONE-BASED ANTIFUNGAL AGENTS UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2018-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180009741-A1 BISHYDRAZONE-BASED ANTIFUNGAL AGENTS DPM1, ERG28, SUCLG1 RAB9A 3483/4885NPC1 928/4885SMN1; SMN2 4460/4885
US-10173968-B2 Bishydrazone-based antifungal agents DPM1, ERG28, SUCLG1 RAB9A 3483/4885NPC1 928/4885SMN1; SMN2 4460/4885
US-20200024224-A1 ANTIFUNGAL COMPOUNDS AND METHODS OF FORMING THE SAME DPM1, ERG28, SUCLG1 RAB9A 3696/4885NPC1 544/4885SMN1; SMN2 4136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.